Citation Impact
Citing Papers
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules
2004 StandoutNobel
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens
1987 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
T-cell-receptor gene therapy
2002
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
2000
Expression of a single transfected cDNA converts fibroblasts to myoblasts
1987 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
2000
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors
2005
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
2008
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
2002 StandoutNobel
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
1998 StandoutNature
Immunotherapy through TCR gene transfer
2001
Targeting tumours with genetically enhanced T lymphocytes
2003
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Function and Specificity of T Cell Subsets in the Mouse
1987
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
An essential role for Scurfin in CD4+CD25+ T regulatory cells
2003 StandoutNobel
CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
1998
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
T-cell antigen receptor genes and T-cell recognition
1988 StandoutNature
Strategies for immunotherapy of cancer
2000
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Natural killer cells and viral infections
2003
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
The Pathophysiology and Treatment of Sepsis
2003 Standout
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
2004
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
2006
Cancer vaccines
1998
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
2010
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Limited diversity of γδ antigen receptor genes of thy-1+ dendritic epidermal cells
1988 StandoutNobel
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Transfer of a TCR Gene Derived from a Patient with a Marked Antitumor Response Conveys Highly Active T-Cell Effector Functions
2005
Molecular Mechanism of the Activation-Induced Cell Death Inhibition Mediated by a p70 Inhibitory Killer Cell Ig-Like Receptor in Jurkat T Cells
2002
Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8+ T Cells
2002
Adoptive Immunotherapy for Cancer or Viruses
2014
Immunological Surveillance of Tumors in the Context of Major Histocompatibility Complex Restriction of T Cell Function
1984 StandoutNobel
Somatic cell variants of H-2k: b: A point mutation in the first extracellular domain results in altered immune recognition
1986
Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity
1983 Nature
The mouse T cell receptor: Structural heterogeneity of molecules of normal T cells defined by Xenoantiserum
1983 StandoutNobel
High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens
2003
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Low frequency of somatic mutation in beta-chain variable region genes of human T-cell receptors.
1985 StandoutNobel
Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
1999
Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
2000 StandoutNobel
Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.
1991 StandoutNobel
Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 Stability
2006
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins
1984 Nature
Tolerance induction by thymic medullary epithelium.
1992 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Limited diversity of the rearranged T-cell γ gene
1985 StandoutNatureNobel
The lymphoproliferative defect in CTLA-4–deficient mice is ameliorated by an inhibitory NK cell receptor
2002 StandoutNobel
T-cell gamma gene is allelically but not isotypically excluded and is not required in known functional T-cell subsets.
1987 StandoutNobel
High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
1999
Developmental regulation of T-cell receptor gene expression
1985 StandoutNatureNobel
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
1998
Diversity of murine gamma genes and expression in fetal and adult T lymphocytes
1986 StandoutNatureNobel
Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells
2005 Nobel
Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.
1996
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences
1984 StandoutNatureNobel
A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes
1984 StandoutNatureNobel
Chromosomal Locations of the Murine T-Cell Receptor Alpha-Chain Gene and the T-Cell Gamma Gene
1985 StandoutScienceNobel
Decreased tumor surveillance in perforin-deficient mice.
1996
The T lymphocyte antigen receptor—paradigm lost
1982 Nature
Structural analysis of an HLA-B27 functional variant: identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes.
1985
Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens.
1986 StandoutNobel
Biosynthesis and processing of murine T-cell antigen receptor
1984 StandoutNobel
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
1990 StandoutScienceNobel
Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules
1981
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Apoptosis in sepsis: a new target for therapeutic exploration
2001
CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
2003
A structural somatic variant of the Kk antigen is generated by point mutation
1985
Serial Analysis of Gene Expression
1995 StandoutScience
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
Structural Analysis of the Functional Sites of Class I HLA Antigens
1985
Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
1998
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
2007 StandoutNobel
Therapeutic cancer vaccines
2015
Recognition of Fresh Human Tumor by Human Peripheral Blood Lymphocytes Transduced with a Bicistronic Retroviral Vector Encoding a Murine Anti-p53 TCR
2005
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
1986 StandoutNature
Immunization with a Lymphocytic Choriomeningitis Virus Peptide Mixed with Heat Shock Protein 70 Results in Protective Antiviral Immunity and Specific Cytotoxic T Lymphocytes
1998
VARIATION IN AVIAN RETROVIRUS GENOMES*
1980
Works of C.J.M. Melief being referenced
Genetic differences unrelated toH-2 inH-2 congenic mice
1978
Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells
2001
Cleavage of FLICE (caspase‐8) by granzyme B during cytotoxic T lymphocyte‐induced apoptosis
1997
Remodelling the H-2 map
1983
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
2001
A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
1982
Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutants.
1980
Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors.
1996
clone recognizing a wild-type p53-derived peptide Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte
1996